MaxCyte, Inc. (LON:MXCT) Insider Sells £185,033.32 in Stock October 4, 2024 by InsiderTrades.com Share MaxCyte, Inc. (LON:MXCT - Get Free Report) insider Stan Erck sold 47,689 shares of the business's stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of GBX 388 ($5.19), for a total transaction of £185,033.32 ($247,503.10). MaxCyte Price PerformanceMaxCyte stock opened at GBX 281 ($3.76) on Friday. The company has a current ratio of 14.31, a quick ratio of 14.38 and a debt-to-equity ratio of 8.37. The company has a fifty day simple moving average of GBX 317.47 and a 200-day simple moving average of GBX 332.92. The stock has a market cap of £295.30 million, a P/E ratio of -1,124.00 and a beta of 1.13. MaxCyte, Inc. has a 12-month low of GBX 180 ($2.41) and a 12-month high of GBX 430 ($5.75). About MaxCyte (Get Free Report)MaxCyte, Inc, a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering.Recommended StoriesFive stocks we like better than MaxCyteHow to Use the MarketBeat Excel Dividend CalculatorWhen Is the Best Time to Invest in Mutual Funds?Differences Between Momentum Investing and Long Term Investing Is NVIDIA Stock in a Correction or Consolidation? What is a buyback in stocks? A comprehensive guide for investors3 Oversold Stocks with Big RSI Rebound PotentialThis instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected]. Insider Buying or Selling at MaxCyte? Sign-up to receive InsiderTrades.com's daily insider buying and selling report for MaxCyte and related companies. More From MarketBeatCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored7 Oversold Stocks That Could Be Setting Up for a RallyIn 2024, investors are still wrestling with uncertainty. Will there be rate cuts, and what will they mean for ...MarketBeatTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored7 Logistics Stocks That Could Soar if Ports CloseWhen the clock strikes midnight on October 1, 2024, dockworkers at dozens of ports throughout the United State...MarketBeatShocking New Forecast From Bear Market ExpertAnybody who followed my recommendations could have gone 11-for-11 on the year. Now, for the first time, I'm...Opportunistic Trader | Sponsored7 Housing Stocks to Buy Regardless of Interest Rate ChangesAccording to the Bankrate survey of large lenders, the average interest rate on a 30-year fixed-rate mortgage ...MarketBeatBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored20 "Past Their Prime" Stocks to Dump From Your PortfolioDid you know the S&P 500 as we know it today does not look anything close to what it looked like 30 years ...MarketBeat Free Insider Buying and Selling Newsletter Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report. From Our PartnersCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredShocking New Forecast From Bear Market ExpertAnybody who followed my recommendations could have gone 11-for-11 on the year. Now, for the first time, I'm...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | Sponsored Most Read This MonthInsiders Are Betting Big on These 2 StocksInsider Selling: American Lithium Corp. (CVE:LI) Director Sells 30,000 Shares of StockInsiders Hold Tight as Helen of Troy Prepares for a Major ReboundInsider Selling: GameStop Corp. (NYSE:GME) Insider Sells 1,972 Shares of StockEnergy Fuels Inc. (TSE:EFR) Senior Officer Logan Shumway Buys 1,500 SharesOkta, Inc. (NASDAQ:OKTA) CEO Sells $2,478,369.52 in StockSurf Air Mobility Inc. (NYSE:SRFM) Major Shareholder Palantir Technologies Inc. Acquires 1,270,869 SharesInsider Selling: Alphabet Inc. (NASDAQ:GOOGL) CEO Sells 22,500 Shares of StockRecent ArticlesSilvercorp Metals Inc. (TSE:SVM) Senior Officer Sells C$10,515.00 in StockEntrada Therapeutics, Inc. (NASDAQ:TRDA) Insider Natarajan Sethuraman Sells 600 SharesGordon Keep Sells 60,000 Shares of Oceanic Iron Ore Corp. (CVE:FEO) StockSonglin Ye Purchases 200 Shares of BQE Water Inc. (CVE:BQE) StockImperial Metals Co. (TSE:III) Director Purchases C$11,766.00 in StockInsider Selling: The Vita Coco Company, Inc. (NASDAQ:COCO) COO Sells 400 Shares of StockInsider Buying: Generation Mining Limited (TSE:GENM) Director Purchases 60,500 Shares of StockInsider Selling: Kraken Robotics Inc. (CVE:PNG) Senior Officer Sells 28,000 Shares of Stock
